Providing a diverse range of perspectives from bullish to bearish, 13 analysts have published ratings on DocuSign DOCU in the last three months.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 3 | 5 | 2 | 0 |
| Last 30D | 0 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 2 | 1 | 5 | 1 | 0 |
| 3M Ago | 1 | 1 | 0 | 1 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $99.69, a high estimate of $124.00, and a low estimate of $70.00. This upward trend is apparent, with the current average reflecting a 32.78% increase from the previous average price target of $75.08.
Investigating Analyst Ratings: An Elaborate Study
A comprehensive examination of how financial experts perceive DocuSign is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Patrick Walravens | JMP Securities | Maintains | Market Outperform | $124.00 | $124.00 |
| Tyler Radke | Citigroup | Raises | Buy | $113.00 | $87.00 |
| Josh Baer | Morgan Stanley | Raises | Equal-Weight | $97.00 | $62.00 |
| Karl Keirstead | UBS | Raises | Neutral | $100.00 | $60.00 |
| Rishi Jaluria | RBC Capital | Raises | Sector Perform | $90.00 | $57.00 |
| Michael Turrin | Wells Fargo | Raises | Underweight | $70.00 | $50.00 |
| Rob Owens | Piper Sandler | Raises | Neutral | $90.00 | $60.00 |
| Brent Thill | Jefferies | Raises | Buy | $115.00 | $95.00 |
| Patrick Walravens | JMP Securities | Raises | Market Outperform | $124.00 | $108.00 |
| William Power | Baird | Raises | Neutral | $100.00 | $59.00 |
| Mark Murphy | JP Morgan | Raises | Underweight | $70.00 | $50.00 |
| Brent Thill | Jefferies | Raises | Buy | $95.00 | $80.00 |
| Patrick Walravens | JMP Securities | Raises | Market Outperform | $108.00 | $84.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to DocuSign. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of DocuSign compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for DocuSign's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
To gain a panoramic view of DocuSign's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on DocuSign analyst ratings.
Discovering DocuSign: A Closer Look
Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and provide legally binding e-signatures from nearly any device. The company was founded in 2003 and completed its initial public offering in May 2018.
DocuSign: A Financial Overview
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: DocuSign's remarkable performance in 3 months is evident. As of 31 October, 2024, the company achieved an impressive revenue growth rate of 7.77%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: DocuSign's net margin excels beyond industry benchmarks, reaching 8.27%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): DocuSign's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 3.16%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): DocuSign's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 1.66%, the company may face hurdles in achieving optimal financial performance.
Debt Management: DocuSign's debt-to-equity ratio is below the industry average. With a ratio of 0.07, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
The Significance of Analyst Ratings Explained
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
